Phibro Animal Health (PAHC) reported $1.3B in revenue for fiscal 2025, +27.4% year on year. That ranks #1612 by revenue among 2853 SEC filers and #148 in Healthcare. Net income was $48.3M, a net margin of 3.7%. Revenue has grown 5.4% a year on average since 2012 ($654M then). The fiscal 2025 balance sheet shows $1.4B in total assets, $55.5M in cash and $604M in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.3B | +27.4% | FY20252025-06-30 |
| Gross profitGrossProfit | $400M | +27.7% | FY20252025-06-30 |
| Operating incomeOperatingIncomeLoss | $110M | +107.2% | FY20252025-06-30 |
| Net incomeNetIncomeLoss | $48.3M | +1,897.7% | FY20252025-06-30 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $80.1M | −8.5% | FY20252025-06-30 |
| Capital expenditurePaymentsToAcquireProductiveAssets | $38.3M | −7.1% | FY20252025-06-30 |
| Total assetsAssets | $1.4B | +9.3% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $332M | +34.7% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $55.5M | −17.3% | FY20252025-12-31 |
| Long-term debtLongTermDebtNoncurrent | $604M | −3.1% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $384M | $24.0M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 93 of 161 companies compared | 3.7% | |
| Operating marginRank 90 of 160 companies compared | 8.5% | |
| R&D as share of revenueRank 93 of 102 companies compared | 1.8% | |
| Cash as share of revenueRank 126 of 160 companies compared | 4.3% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Phibro Animal Health Corp
- Ticker
- PAHC
- Exchange
- Nasdaq
- SIC classification
- Pharmaceutical Preparations (2834)
- Fiscal year end
- 06-30
- CIK
- 0001069899
Filings
- 10-KAug 26, 2026Open filing →
- 10-QMay 6, 2026Open filing →
- 10-QFeb 4, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| ConmedCNMD | $1.4B | $47.1M |
| Stevanato GroupSTVN | $1.3B | $158M |
| HaemoneticsHAE | $1.3B | $97,308 |
| Phibro Animal HealthPAHC | $1.3B | $48.3M |
| ProgynyPGNY | $1.3B | $58.5M |
| Curaleaf HoldingsCURLF | $1.3B | −$231M |
| Lakefront BiotherapeuticsLKFT | $1.3B | $363M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Phibro Animal Health — Key figures |url=https://companiesranked.com/en/company/phibro-animal-health |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Phibro Animal Health — Key figures. CompaniesRanked. https://companiesranked.com/en/company/phibro-animal-healthBibTeX
@misc{companiesranked-en-company-phibro-animal-health-2026,
author = {{CompaniesRanked}},
title = {{Phibro Animal Health — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/phibro-animal-health}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001104659-26-101493 · August 26, 2026
{{cite web |title=Phibro Animal Health — Key figures — 10-K (0001104659-26-101493) |url=https://www.sec.gov/Archives/edgar/data/1069899/000110465926101493/pahc-20260630x10k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-26}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.